Prosperity Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-964
Closed -$356K 173
2024
Q4
$356K Buy
964
+91
+10% +$38.1K 0.18% 111
2024
Q3
$454K Buy
873
+104
+14% +$55.6K 0.25% 92
2024
Q2
$417K Buy
769
+32
+4% +$16.9K 0.26% 87
2024
Q1
$382K Buy
737
+32
+5% +$15.9K 0.24% 93
2023
Q4
$332K Buy
705
+25
+4% +$11.6K 0.23% 87
2023
Q3
$296K Buy
680
+25
+4% +$11.3K 0.24% 80
2023
Q2
$291K Buy
655
+49
+8% +$22.6K 0.26% 88
2023
Q1
$279K Buy
+606
New +$288K 0.28% 73

Other funds holding ELV

Prosperity Financial Group's ELV Position: Q1 2025 in Review

Prosperity Financial Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 964 shares — an estimated $356K sold.

Prosperity Financial Group first reported a position in ELV in Q1 2023 and held it in 8 quarters. The position peaked at $454K in Q3 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Prosperity Financial Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Prosperity Financial Group sold 964 Elevance Health shares in Q1 2025, an estimated $356K.
  • Prosperity Financial Group first reported a position in Elevance Health in Q1 2023 and held it in 8 quarters.
  • Prosperity Financial Group's Elevance Health position peaked at $454K in Q3 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Prosperity Financial Group's 13F filing for Q1 2025, filed 15 May 2025.